ClinicaliQ Trial Snapshot
- Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme – A Single-arm Study — Recruiting • Non-phase study • Oncology • NCT07554677.
- What is being tested: A feasibility study evaluating a co-designed, pre-radiotherapy exercise programme consisting of 20-minute exercise sessions for patients with stage I-III non-small cell lung cancer undergoing radiotherapy treatment.
- Patient eligibility overview: The trial includes adults with stage I-III non-small cell lung cancer who are scheduled to receive radiotherapy, with the programme designed to be delivered prior to commencing radiation treatment.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this clinical trial is to understand the feasibility of a co-designed, pre-radiotherapy exercise programme for people with stage I-III non-small cell lung cancer. This involves people with lung cancer engaging in 20 minutes exercises sessions performed within the radiotherapy department and immediately before each treatment at a personalised intensity. The main questions it aims to answer are: To understand the acceptability of the exercise programme through monitoring recruitment rates, attendance of the exercise sessions, and adherence to prescribed exercise intensities. Adverse events will also be monitored to…
Eligibility Snapshot
- : * Patients with clinically or histologically confirmed NSCLC stages 1-3. * Planned to receive treatment with curative intention radiation as primary treatment. * Eastern Cooperative Oncology Group (ECOG) performance status 0-2. * At least 18 years of age. * Can understand and communicate in English. * Deemed safe to participate in moderate-intensity exercise and for ECG monitored maximal fitness test through the completion of a medical clearance form by their treating physician. * Able to provide written and informed consent.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.